CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis.

TitleCUL4A abrogation augments DNA damage response and protection against skin carcinogenesis.
Publication TypeJournal Article
Year of Publication2009
AuthorsLiu L, Lee S, Zhang J, Peters SB, Hannah J, Zhang Y, Yin Y, Koff A, Ma L, Zhou P
JournalMol Cell
Volume34
Issue4
Pagination451-60
Date Published2009 May 14
ISSN1097-4164
KeywordsAnimals, Cells, Cultured, Cullin Proteins, Cyclin-Dependent Kinase Inhibitor p21, DNA Damage, DNA Repair, DNA-Binding Proteins, Fibroblasts, Genes, cdc, Mice, Mice, Knockout, Skin Neoplasms, Transgenes, Ultraviolet Rays
Abstract

It is intuitively obvious that the ability of a cell to repair DNA damage is saturable, either by limitation of enzymatic activities, the time allotted to achieve their function, or both. However, very little is known regarding the mechanisms that establish such a threshold. Here we demonstrate that the CUL4A ubiquitin ligase restricts the cellular repair capacity by orchestrating the concerted actions of nucleotide excision repair (NER) and the DNA damage-responsive G1/S checkpoint through selective degradation of the DDB2 and XPC DNA damage sensors and the p21/CIP1/WAF1 checkpoint effector. We generated Cul4a conditional knockout mice and observed that skin-specific Cul4a ablation dramatically increased resistance to UV-induced skin carcinogenesis. Our findings reveal that wild-type cells do not operate at their full DNA repair potential, underscore the critical role of CUL4A in establishing the cellular DNA repair threshold, and highlight the potential augmentation of cellular repair proficiency by pharmacological CUL4A inhibition.

DOI10.1016/j.molcel.2009.04.020
Alternate JournalMol Cell
PubMed ID19481525
PubMed Central IDPMC2722740
Grant ListR01 CA098210-04 / CA / NCI NIH HHS / United States
R01 ES014482-04 / ES / NIEHS NIH HHS / United States
R01 CA098210-06A1 / CA / NCI NIH HHS / United States
R56 CA098210-06 / CA / NCI NIH HHS / United States
R01 CA098210-05 / CA / NCI NIH HHS / United States
R01 CA118085 / CA / NCI NIH HHS / United States
R01 CA098210-03 / CA / NCI NIH HHS / United States
CA098210 / CA / NCI NIH HHS / United States
R01 CA118085-04 / CA / NCI NIH HHS / United States
ES014482 / ES / NIEHS NIH HHS / United States
R01 CA118085-03 / CA / NCI NIH HHS / United States
R01 ES014482 / ES / NIEHS NIH HHS / United States
R01 CA118085-02 / CA / NCI NIH HHS / United States
R01 CA118085-01 / CA / NCI NIH HHS / United States
R01 CA098210 / CA / NCI NIH HHS / United States
R01 CA098210-01A1 / CA / NCI NIH HHS / United States
R01 CA098210-02 / CA / NCI NIH HHS / United States
CA118085 / CA / NCI NIH HHS / United States
R56 CA098210 / CA / NCI NIH HHS / United States
Related Lab: 
Related Faculty: 
Pengbo Zhou, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700